Perfluoroalkyl substances and breast cancer tissue biomarkers
全氟烷基物质与乳腺癌组织生物标志物
基本信息
- 批准号:10738987
- 负责人:
- 金额:$ 40.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-07 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Acinus organ componentAddressAffectAgingAgreementBiological AssayBiological MonitoringBloodBlood specimenBreastBreast Cancer Risk FactorBreast CarcinogenesisBreast FeedingCarcinogensChildbirthCollectionComputer softwareDataDevelopmentDiagnosticDigital MammographyEnvironmental PollutionExploratory/Developmental GrantExposure toFutureGoalsHealthHumanHuman MilkInvestigationLaboratoriesLaboratory StudyLiteratureMammary Gland ParenchymaMammary glandMammographic DensityMammographyMeasurableMeasurementMeasuresMedical HistoryMorphologyPPAR alphaPathway interactionsPhysiologicalPoly-fluoroalkyl substancesPopulationPostmenopausePredispositionProductionPublic HealthReportingReproductive HistoryResistanceResourcesSample SizeSamplingSerumStainsStructureSulfateTerminal Ductal Lobular UnitTimeTissue BanksTissue DonationsTissue SampleWaterWorkbioaccumulationbiobankcancer riskcarcinogenesiscarcinogenicityconsumer productcostepidemiologic dataepidemiology studyexperienceexperimental studyhealthy volunteerhuman tissueinnovationinsightmalignant breast neoplasmmammary gland developmentmilk productionnovelperfluorooctaneperfluorooctanoic acidprogramssteroid hormonetissue biomarkersvolunteer
项目摘要
PROJECT SUMMARY
Per- and polyfluoroalkyl substances (PFAS) are possible carcinogens and have demonstrated detrimental
effects on the mammary gland in experimental studies. PFAS are widely used in non-stick, water-resistant, and
stain-resistant coatings for consumer products. Nearly all U.S. residents have detectable PFAS in their blood,
and their environmental persistence and potential for bioaccumulation raises significant concerns about their
long-term health effects. Epidemiologic studies offer preliminary evidence that exposure to certain PFAS may
be associated with a doubling of breast cancer risk, and laboratory studies also support breast carcinogenesis
following PFAS exposure. Exploring morphological features of human breast tissue can provide important
insight on breast carcinogenesis and the impacts of specific exposures. No prior studies have directly explored
how human breast tissue is affected by PFAS exposure. Terminal ductal lobular unit (TDLU) involution and
mammographic density (MD) are features of human breast tissue that are strongly and independently
associated with breast cancer risk and likely lie on the causal pathway. Our overall goal is to understand if
PFAS contribute to breast cancer development. Toward this goal, we propose a novel investigation to
understand if serum concentrations of common PFAS are associated with TDLU involution and MD. We will
leverage the unique resources of the Susan G. Komen for the Cure Tissue Bank (KTB) biorepository, which
includes ~9,000 samples of breast tissue donated by healthy volunteers along with relevant epidemiologic data
(e.g. medical history, reproductive history); a subset of volunteers also provided a blood sample and/or access
to mammograms. We will select the 286 postmenopausal KTB donors with available: a) stored serum sample,
b) prior TDLU measurements, and c) mammogram. We will measure a panel of common PFAS in serum
samples using a validated assay at a highly experienced and reputable laboratory. We will address the
following Specific Aims: to assess associations between serum PFAS concentrations and quantitative
measures of 1) TDLU involution and 2) MD. We have an excellent opportunity to capitalize on pre-existing data
and biospecimens from the KTB for an innovative exploration of PFAS and these breast tissue features, each
of which is independently predictive of breast cancer risk. The proposed work will provide insight on
physiologic mechanisms and generate critical preliminary data critical for future larger epidemiologic studies of
PFAS and breast cancer risk. As PFAS exposure is ubiquitous, even a small association with breast cancer
risk would substantially impact public health.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine Whitney Reeves其他文献
Katherine Whitney Reeves的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine Whitney Reeves', 18)}}的其他基金
Phthalate Metabolites and Breast Cancer Risk in the Women's Health Initiative
妇女健康倡议中的邻苯二甲酸盐代谢物和乳腺癌风险
- 批准号:
9054118 - 财政年份:2015
- 资助金额:
$ 40.53万 - 项目类别:
Phthalate Metabolites and Breast Cancer Risk in the Women's Health Initiative
妇女健康倡议中的邻苯二甲酸盐代谢物和乳腺癌风险
- 批准号:
9237267 - 财政年份:2015
- 资助金额:
$ 40.53万 - 项目类别:
Depression, Antidepressant Use, and Breast Cancer Risk
抑郁症、抗抑郁药的使用和乳腺癌风险
- 批准号:
8704461 - 财政年份:2014
- 资助金额:
$ 40.53万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.53万 - 项目类别:
Research Grant